Status:

COMPLETED

DSS: Diabetes Surgery Study - Intensive Medical Management of Type 2 Diabetes, With and Without Gastric Bypass Surgery

Lead Sponsor:

Medtronic - MITG

Conditions:

Type 2 Diabetes

Cardiovascular Disease

Eligibility:

All Genders

30-67 years

Phase:

NA

Brief Summary

The present study is the first stage of a research program whose ultimate goal is to conduct a randomized clinical trial involving type 2 diabetics with BMI from 30.0 to 39.9 kg/m2. This program will ...

Eligibility Criteria

Inclusion

  • Age 30 to 67 years at eligibility visit.
  • Diagnosed with T2DM at least 6 months prior to enrollment, under the active care of a doctor for at least the six months prior to enrollment, and HbA1c ≥ 8.0 %.
  • Body Mass Index (BMI) ≥ 30.0 kg/m2 and ≤ 39.9 kg/m2 at eligibility visit.
  • Willingness to accept random assignment to either treatment group.
  • Expect to live or work within approximately one hour's traveling time from the study clinic for the duration of the two-year trial.
  • Willingness to comply with the follow-up protocol and successful completion of the run-in (described below).
  • Written informed consent.

Exclusion

  • Cardiovascular event (myocardial infarction, acute coronary syndrome, coronary artery angioplasty or bypass, stroke) in the past six months.
  • Current evidence of congestive heart failure, angina pectoris, or symptomatic peripheral vascular disease.
  • Cardiac stress test indicating that surgery or IMM would not be safe.
  • Pulmonary embolus or thrombophlebitis in the past six months.
  • Cancer of any kind (except basal cell skin cancer or cancer in situ) unless documented to be disease-free for five years.
  • Significant anemia (hemoglobin 1.0 g or more below normal range) or history of coagulopathy.
  • Serum creatinine ≥ 1.5 mg/dl.
  • HbA1c \> 14.0%.

Key Trial Info

Start Date :

February 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2016

Estimated Enrollment :

120 Patients enrolled

Trial Details

Trial ID

NCT00641251

Start Date

February 1 2008

End Date

December 1 2016

Last Update

November 29 2017

Active Locations (5)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (5 locations)

1

University of Minnesota

Minneapolis, Minnesota, United States, 55414

2

Mayo Clinic

Rochester, Minnesota, United States, 55905

3

Columbia University

New York, New York, United States, 10032

4

Min-Sheng General Hospital

Taipei, Taiwan